Increased serum levels and tissue expression of matrix metalloproteinase-12 in patients with systemic sclerosis: Correlation with severity of skin and pulmonary fibrosis and vascular damage

Annals of the Rheumatic Diseases

Volumn 71, Issue 6, 2012, Pages 1064-1072

  Manetti, Mirko ^a   Guiducci, Serena ^a   Romano, Eloisa ^a   Bellando Randone, Silvia ^a   Conforti, Maria Letizia ^a   Ibba Manneschi, Lidia ^a   Matucci Cerinic, Marco ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MACROPHAGE ELASTASE;

ADULT; ARTICLE; CELLULAR DISTRIBUTION; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; DISEASE SEVERITY; ENDOTHELIUM CELL; ENZYME BLOOD LEVEL; ENZYME LOCALIZATION; FEMALE; FINGER ULCER; HUMAN; HUMAN TISSUE; INFLAMMATORY CELL; INTERSTITIAL LUNG DISEASE; KERATINOCYTE; LUNG BIOPSY; LUNG FIBROSIS; LUNG PARENCHYMA; MAJOR CLINICAL STUDY; MALE; MICROANGIOPATHY; MOLECULAR PATHOLOGY; MYOFIBROBLAST; NAIL DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN BIOPSY; SKIN FIBROBLAST; SKIN FIBROSIS; SYSTEMIC SCLEROSIS; TISSUE DISTRIBUTION;

AGED; BIOLOGICAL MARKERS; BIOPSY; FEMALE; FIBROSIS; HUMANS; LUNG; MALE; MATRIX METALLOPROTEINASE 12; MICROVESSELS; MIDDLE AGED; PULMONARY FIBROSIS; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX; SKIN;

EID: 84860917548     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2011-200837     Document Type: Article

References (39)

1. Varga J, Abraham D. Systemic sclerosis: a prototypic multisystem fibrotic disorder. J Clin Invest 2007;117:557-67. (Pubitemid 46348510)
2. Gabrielli A, Avvedimento EV, Krieg T. Scleroderma. N Engl J Med 2009;360:1989-2003.
3. Manetti M, Guiducci S, Ibba-Manneschi L, et al. Mechanisms in the loss of capillaries in systemic sclerosis: angiogenesis versus vasculogenesis. J Cell Mol Med 2010;14(6A):1241-54.
4. Guiducci S, Giacomelli R, Cerinic MM. Vascular complications of scleroderma. Autoimmun Rev 2007;6:520-3. (Pubitemid 47374612)
5. Hesselstrand R, Scheja A, Akesson A. Mortality and causes of death in a Swedish series of systemic sclerosis patients. Ann Rheum Dis 1998;57:682-6. (Pubitemid 28558973)
6. Wynn TA. Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. J Clin Invest 2007;117:524-9. (Pubitemid 46348506)
7. Pardo A, Selman M. Matrix metalloproteases in aberrant fibrotic tissue remodeling. Proc Am Thorac Soc 2006;3:383-8. (Pubitemid 43845417)
8. Klein T, Bischoff R. Physiology and pathophysiology of matrix metalloproteases. Amino Acids 2011;41:271-90.
9. Amalinei C, Caruntu ID, Giusca SE, et al. Matrix metalloproteinases involvement in pathologic conditions. Rom J Morphol Embryol 2010;51:215-28.
10. Johnson JL, Devel L, Czarny B, et al. A selective matrix metalloproteinase-12 inhibitor retards atherosclerotic plaque development in apolipoprotein E-knockout mice. Arterioscler Thromb Vasc Biol 2011;31:528-35.
11. Kerkelä E, Ala-Aho R, Jeskanen L, et al. Expression of human macrophage metalloelastase (MMP-12) by tumor cells in skin cancer. J Invest Dermatol 2000;114:1113-9. (Pubitemid 30415226)
12. Vaalamo M, Kariniemi AL, Shapiro SD, et al. Enhanced expression of human metalloelastase (MMP-12) in cutaneous granulomas and macrophage migration. J Invest Dermatol 1999;112:499-505. (Pubitemid 29171941)
13. Salmela MT, Pender SL, Reunala T, et al. Parallel expression of macrophage metalloelastase (MMP-12) in duodenal and skin lesions of patients with dermatitis herpetiformis. Gut 2001;48:496-502. (Pubitemid 32234793)
14. Uchio K, Sawada K, Manabe N. Expression of macrophage metalloelastase (MMP-12) in podocytes of hereditary nephrotic mice (ICGN strain). J Vet Med Sci 2009;71:305-12.
15. Lagente V, Le Quement C, Boichot E. Macrophage metalloelastase (MMP-12) as a target for inflammatory respiratory diseases. Expert Opin Ther Targets 2009;13:287-95.
16. Kang HR, Cho SJ, Lee CG, et al. Transforming growth factor (TGF)-beta1 stimulates pulmonary fibrosis and inflammation via a Bax-dependent, bid-activated pathway that involves matrix metalloproteinase-12. J Biol Chem 2007;282:7723-32.
17. Matute-Bello G, Wurfel MM, Lee JS, et al. Essential role of MMP-12 in Fas-induced lung fibrosis. Am J Respir Cell Mol Biol 2007;37:210-21. (Pubitemid 47255004)
18. Xu Z, Shi H, Li Q, et al. Mouse macrophage metalloelastase generates angiostatin from plasminogen and suppresses tumor angiogenesis in murine colon cancer. Oncol Rep 2008;20:81-8.
19. Cheng P, Jiang FH, Zhao LM, et al. Human macrophage metalloelastase correlates with angiogenesis and prognosis of gastric carcinoma. Dig Dis Sci 2010;55:3138-46.
20. Serratì S, Cinelli M, Margheri F, et al. Systemic sclerosis fibroblasts inhibit in vitro angiogenesis by MMP-12-dependent cleavage of the endothelial cell urokinase receptor. J Pathol 2006;210:240-8. (Pubitemid 44463939)
21. D'Alessio S, Fibbi G, Cinelli M, et al. Matrix metalloproteinase 12-dependent cleavage of urokinase receptor in systemic sclerosis microvascular endothelial cells results in impaired angiogenesis. Arthritis Rheum 2004;50:3275-85. (Pubitemid 39372005)
22. Manetti M, Ibba-Manneschi L, Fatini C, et al. Association of a functional polymorphism in the matrix metalloproteinase-12 promoter region with systemic sclerosis in an Italian population. J Rheumatol 2010;37:1852-7.
23. LeRoy EC, Black C, Fleischmajer R, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988;15:202-5.
24. Medsger TA Jr, Steen VD. Classification, prognosis. In: Clements PJ, Furst DE, eds. Systemic sclerosis. Second edition. Philadelphia: Lippincott Williams & Wilkins, 1996:51-79.
25. Valentini G, Matucci Cerinic M. Disease-specific quality indicators, guidelines and outcome measures in scleroderma. Clin Exp Rheumatol 2007;25(6 Suppl 47):159-62.
26. Clements P, Lachenbruch P, Siebold J, et al. Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol 1995;22:1281-5.
27. Cutolo M, Sulli A, Pizzorni C, et al. Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol 2000;27:155-60. (Pubitemid 30058643)
28. Manetti M, Ibba-Manneschi L, Liakouli V, et al. The IL1-like cytokine IL33 and its receptor ST2 are abnormally expressed in the affected skin and visceral organs of patients with systemic sclerosis. Ann Rheum Dis 2010;69:598-605.
29. Saarialho-Kere U, Kerkelä E, Jeskanen L, et al. Accumulation of matrilysin (MMP-7) and macrophage metalloelastase (MMP-12) in actinic damage. J Invest Dermatol 1999;113:664-72. (Pubitemid 29489633)
30. Sternlicht MD, Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 2001;17:463-516. (Pubitemid 33096184)
31. Garbacki N, Di Valentin E, Piette J, et al. Matrix metalloproteinase 12 silencing: a therapeutic approach to treat pathological lung tissue remodeling? Pulm Pharmacol Ther 2009;22:267-78.
32. Demedts IK, Morel-Montero A, Lebecque S, et al. Elevated MMP-12 protein levels in induced sputum from patients with COPD. Thorax 2006;61:196-201.
33. Furst D, Khanna D, Matucci-Cerinic M, et al. Systemic sclerosis: continuing progress in developing clinical measures of response. J Rheumatol 2007;34:1194-200. (Pubitemid 46774874)
34. Madala SK, Pesce JT, Ramalingam TR, et al. Matrix metalloproteinase 12-deficiency augments extracellular matrix degrading metalloproteinases and attenuates IL-13-dependent fibrosis. J Immunol 2010;184:3955-63.
35. Sato M, Hirayama S, Lara-Guerra H, et al. MMP-dependent migration of extrapulmonary myofibroblast progenitors contributing to posttransplant airway fibrosis in the lung. Am J Transplant 2009;9:1027-36.
36. Moinzadeh P, Krieg T, Hellmich M, et al. Elevated MMP-7 levels in patients with systemic sclerosis: correlation with pulmonary involvement. Exp Dermatol 2011;20:770-3.
37. Koolwijk P, Sidenius N, Peters E, et al. Proteolysis of the urokinase-type plasminogen activator receptor by metalloproteinase-12: implication for angiogenesis in fibrin matrices. Blood 2001;97:3123-31.
38. Margheri F, Serratì S, Lapucci A, et al. Modulation of the angiogenic phenotype of normal and systemic sclerosis endothelial cells by gain-loss of function of pentraxin 3 and matrix metalloproteinase 12. Arthritis Rheum 2010;62:2488-98.
39. Dwivedi A, Slater SC, George SJ. MMP-9 and -12 cause N-cadherin shedding and thereby beta-catenin signalling and vascular smooth muscle cell proliferation. Cardiovasc Res 2009;81:178-86.